COVID-19 and Fulminant Clostridium difficile Colitis Co-Infection

Abstract

The development of Clostridium difficile infection in COVID-19 patients is an understudied complication of the disease. Herein, we present the case of a 46-year-old man who developed severe healthcare-associated C. difficile infection leading to toxic megacolon and perforation in the setting of COVID-19 infection. It is important to continue to follow guidelines regarding antibiotics in healthcare settings to prevent such complications.

Keywords

• covid-19
• antibiotics
• microbial resistance
• clostridium difficile